Patent details
EP3167888
Title:
TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
Basic Information
- Publication number:
- EP3167888
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP161953559
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- French Title of Invention:
- TRAITEMENT DE PATIENTS SOUFFRANT D'HÉMOGLOBINURIE PAROXYSTIQUE NOCTURNE PAR UN INHIBITEUR DE COMPLÉMENT
- German Title of Invention:
- BEHANDLUNG VON PATIENTEN MIT PAROXYSMALER NÄCHTLICHER HÄMOGLOBINURIE MIT EINEM KOMPLEMENTINHIBITOR
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 01/05/2024
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 13/05/2024
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 01/05/2024
- Unitary Effect Registration Date:
- 13/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 15/03/2007
- Grant date:
- 01/05/2024
- EP Publication Date:
- 17/05/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/05/2024
- EP B1 Publication Date:
- 01/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 15/03/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/04/2024
-
-
- Name:
- Alexion Pharmaceuticals, Inc.
- Address:
- 100 College Street, New Haven, CT 06510, United States (US)
Inventor
1
- Name:
- ROTHER, Russell P.
- Address:
- United States (US)
2
- Name:
- BELL, Leonard
- Address:
- United States (US)
3
- Name:
- EVANS, Mark J.
- Address:
- United States (US)
Priority
- Priority Number:
- 783070 P
- Priority Date:
- 15/03/2006
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/7105;
A61K 38/00;
A61K 39/395;
A61P 7/06;
C07K 16/18;
A61K 9/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202418
- Publication date:
- 01/05/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202424
- Publication date:
- 12/06/2024
- Description:
- Opposition procedure started
3
- Issue number:
- 202423
- Publication date:
- 05/06/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202424
- Publication date:
- 12/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |